“Re-Implantation Strategy After Lead Extraction for Cardiac Device Infection”
“Re-Implantation Strategy After Lead Extraction for Cardiac Device Infection”
复制标题
“心脏装置感染拔除铅后的再植入策略”
DOI：
10.1007/978-3-030-46255-0_7
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
A. Tosetti
中科院分区：
文献类型：
--
作者：
C. Butter;A. Tosetti
心脏植入式电气设备感染 (CIEDI) 是植入起搏器 (PM) 或除颤器 (ICD) 的患者最担心的并发症之一。唯一的治疗方法是完全拔除所有起搏/除颤系统。经静脉导联取出 (TLE) 的结果已取得多项改进，从高风险手术转变为更安全的治疗方法，并在其他几种电生理手术中出现主要并发症。然而，CIEDI 患者的治疗并不会以 TLE 结束，因为在局部甚至全身感染愈合的挑战性环境中，许多患者需要重新植入 PM/ICD。在本章中，我们将讨论 TLE 后重新植入的各个方面：适应症的重新评估、桥接方法、替代方案和时机。还将涵盖新技术在这一特定背景下的使用。
Cardiac implantable electrical device infections (CIEDI) are one of the most feared complications for patients implanted with pacemakers (PM) or defibrillators (ICD). The only curative treatment is complete extraction of all pacing/defibrillation system. Several improvements have been made in the results of transvenous lead extraction (TLE), moving from a high-risk procedure to a more safe treatment with major complications in the range of several other electrophysiological procedures. However, management of patients with CIEDI does not end with TLE, since many of them will require re-implantation of a PM/ICD in the challenging setting of a healing local or even systemic infection. In the present chapter we will discuss the various aspects of re-implantation after TLE: reassessment of indications, bridging approaches, alternative options, and timing. New technologies will also be covered for their use in this particular context.